title: Redo Heller Myotomy for Achalasia in a Patient with Down Syndrome: a Case Report.
abstract: Up to 77% of Down syndrome (DS) patients have associated structural or functional gastrointestinal abnormalities. Functional disturbances, such as processes affecting the enteric nervous system, can often affect the outcome of corrective surgical procedures. Recently, an association between DS and achalasia has been reported. In this report we present a 28-year-old male patient with a history of Down syndrome and achalasia, who presented with recurrent dysphagia, gastroesophageal reflux, and recurrent aspirations. The patient had previously undergone a laparoscopic Heller myotomy with Dor fundoplication. Unfortunately, despite this surgery, he continued to require multiple esophageal dilations, and intraesophageal administration of Botox therapy. Additionally, there were numerous subsequent hospital admissions for recurrent aspiration pneumonia. Evaluation revealed an incomplete myotomy and a revision long Heller myotomy was successfully performed intraabdominally and he is now symptom and aspiration free.
authors.forename: Jessica
authors.initials: J
authors.lastname: Sosa-Stanley
authors.forename: KellyAnn
authors.initials: K
authors.lastname: Vandendool
authors.forename: Jonathan
authors.initials: J
authors.lastname: Kiev
mesh_terms: D000328:Adult; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage; D003680:Deglutition Disorders / Q000209:etiology; D004314:Down Syndrome / Q000150:complications*; D004931:Esophageal Achalasia / Q000209:etiology / Q000601:surgery*; D018662:Fundoplication / Q000379:methods; D005764:Gastroesophageal Reflux / Q000209:etiology; D006801:Humans; D010535:Laparoscopy / Q000379:methods*; D008297:Male; D012086:Reoperation; D016896:Treatment Outcome
chemical_list: D019274:Botulinum Toxins, Type A